Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
Rett syndrome / Posted 2 years ago
To evaluate the efficacy of cannabidiol oral solution (GWP42003-P, CBD-OS) in reducing symptom severity when compared with placebo, in patients with Rett syndrome.
- Study start date : 01/07/2019
- Study end date : 01/08/2021
- Wales-Based Study Contact : please speak to your clinician